Protein nanoparticle delivery platform to deliver genetic payloads into multiple organs for better response and fewer reactions.
Location: United States, Massachusetts, Boston
Employees: 51-200
Total raised: $193M
Founded date: 2021
Investors 3
| Date | Name | Website |
| 08.11.2023 | ARCH Ventu... | archventur... |
| - | F-Prime Ca... | fprimecapi... |
| - | Newpath Ma... | newpath.pa... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 15.02.2023 | Series B | $193M | - |
Mentions in press and media 3
| Date | Title | Description | Source |
| 17.02.2023 | Aera Therapeutics Launches with $193M in Series A and Series... | Aera Therapeutics, a Boston, MA-based biotechnology company providing a proprietary protein nanopart... | finsmes.co... |
| 16.02.2023 | On hunt for better gene med delivery, Aera exits stealth wit... | Led by a 20-year Alnylam veteran, Aera Therapeutics has emerged with $193 million in hand and hopes ... | fiercebiot... |
| - | Aera Therapeutics | “Aera Therapeutics” | fastfounde... |